Skip to main content

Peer Review reports

From: Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis

Original Submission
19 Oct 2015 Submitted Original manuscript
3 Nov 2015 Reviewed Reviewer Report - Doaa Mohamed Badr
20 Nov 2015 Reviewed Reviewer Report - Bilge Aktas
14 Dec 2015 Author responded Author comments - Linh Nugyen
Resubmission - Version 2
14 Dec 2015 Submitted Manuscript version 2
4 Apr 2016 Author responded Author comments - Linh Nugyen
Resubmission - Version 3
4 Apr 2016 Submitted Manuscript version 3
20 May 2016 Author responded Author comments - Linh Nugyen
Resubmission - Version 4
20 May 2016 Submitted Manuscript version 4
7 Jul 2016 Author responded Author comments - Linh Nugyen
Resubmission - Version 5
7 Jul 2016 Submitted Manuscript version 5
Publishing
14 Jul 2016 Editorially accepted
26 Jul 2016 Article published 10.1186/s12885-016-2568-7

You can find further information about peer review here.

Back to article page